Testing effectiveness (Phase 2)Study completedNCT00777231
What this trial is testing
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
Who this might be right for
Sickle Cell Disease
Talaris Therapeutics Inc. 9
Showing 20 of 0 results